<DOC>
	<DOCNO>NCT02250833</DOCNO>
	<brief_summary>A randomized , open-label , single-dose , two-period , two-way , crossover study compare pharmacokinetics safety CKD-828 ( Fixed Dose Combination Tablet ) coadministration telmisartan s-amlodipine health volunteer .</brief_summary>
	<brief_title>CKD-828 ( 80/5mg ) Pharmacokinetic Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>A healthy volunteer 20 55 year old More 50kg within 20 % ideal body weight No congenital chronic diseases medical symptom Appropriate study examination ( laboratory test , ECG etc . ) within 4weeks prior first IP administration Signed informed consent form prior study participation . History relevant hypersensitivity drug Clinical significant disease medical history ( ex . hepato/cholangio , cardio , endo , hemato , onco , CNS etc . ) Active liver disease abnormal laboratory result ( AST ALT Total bilirubin &gt; 1.5*ULN ) SBP &lt; 90mmHg SBP &gt; 150mmHg DBP &lt; 50mmHg DBP &gt; 100mmHg Creatinine clearance &lt; 80mL/min A Disease ( ex.inflammatory intestinal disease , gastric duodenal ulcer , hepatic disease history , gastrointestinal surgery except appendectomy ) may influence absorption , distribution , metabolism excretion drug The evidence severe attack acute disease surgical intervention within 28 day prior first IP administration . A drug abuse heavy caffeine consumer ( 5 cup per day ) regular alcohol consumer ( 21 units/week ) heavy smoker ( 10 cigarette per day ) Taking ETC medicine oriental medicine within 14days Taking OTC medicine within 7days prior first IP administration Abnormal diet ( Especially , grapefruit juice within 7 day prior first IP administration ) may influence absorption , distribution , metabolism excretion drug</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>CKD-828</keyword>
	<keyword>Telmisartan</keyword>
	<keyword>S-amlodipine</keyword>
	<keyword>Pharmacokinetic</keyword>
</DOC>